Browsing: Wegovy
The socioeconomic burdens associated with obesity are palpable, as access to high-quality food, health club memberships, and even the time…
Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart-failure symptoms for patients with diabetes in the latest large trial…
Amid increased concern about the costs of using glucagon-like peptide 1 agonists to treat obesity, some insurers are imposing further…
The weight loss drug Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration last month. This allows…
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000…
Ozempic Maker’s New Weight Loss Pill Beats Wegovy In Early Trial — What To Know About Novo Nordisk’s Amycretin
Topline Ozempic maker Novo Nordisk on Thursday teased a potential successor to its blockbuster weight loss drug Wegovy, the latest…
Goldman Sachs Says Weight Loss Drugs Are Good For Economy, But Obesity Prevention May Be Better
In the February 4, 1735 issue of the Pennsylvania Gazette, Benjamin Franklin wrote that “an ounce of prevention is worth…
Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out-of-pocket for them
The popularity of Novo Nordisk’s weight-loss drugs has been unprecedented and has shown no signs of fading. It’s clearly more…
Novo Nordisk hits $500bn market value, climbing closer to the $1tn club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…